We designed a new way to build miniature fluidic devices to enable personalized cancer treatment

Researchers have developed a simplified, cost-effective method for fabricating microfluidic 'tumor-on-a-chip' devices. This technology allows for personalized cancer treatment testing by recreating a patient's specific tumor environment outside the body.
Why it matters
Making personalized cancer diagnostics more affordable could significantly improve treatment outcomes and accessibility for patients.
by Sara Hassanpour Tamrin, Arindom Sen, The Conversation
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Miniature (microfluidic) devices created using our simplified fabrication method. Credit: Joe McFarland/University of Calgary There is no "one-size-fits-all" treatment for patients living with cancer . Cancer occurs when normal cells in the body genetically mutate and transform into abnormal cells that divide uncontrollably.
In most cases, these cancer cells form a solid mass of tissue called a tumor. The genetic changes that cause a tumor can influence its composition, so two people may have the same type of cancer but different types of tumors . A treatment may then work for one patient but not another .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in